Two molecular signaling pathways underlie the cardiac defects associated with one type of the inherited disorder Noonan syndrome (NS), researchers from Masonic Medical Research Institute, Beth Israel Deaconess Medical Center and Weill Cornell Medicine find in a new study.
The Weill Cornell Graduate School of Medical Sciences has been awarded a competitive grant from the National Institutes of Health to launch a program dedicated to increasing the number and enhancing the success of doctoral students from underrepresented backgrounds.
A newly available drug may improve the effectiveness of immunotherapy in hard-to-treat cancers of the upper urinary tract, suggests a study published by Weill Cornell Medicine and NewYork-Presbyterian investigators.
A new technology devised by scientists at Weill Cornell Medicine and the New York Genome Center (NYGC) enables the measurement of gene mutations and their effects on gene activity within individual cancer cells biopsied from patients.
The Executive M.B.A./M.S. in Healthcare Leadership program, offered jointly by the Weill Cornell Graduate School of Medical Sciences and Cornell’s Samuel Curtis Johnson Graduate School of Management in May celebrated a milestone: graduating its first class of 39 students.
New federal regulations will dictate when and how physicians can order advanced imaging tests for Medicare patients to prevent unnecessary procedures and curb healthcare spending. These rules will achieve their goals only if providers can devote substantial resources and planning ahead of their implementation in 2020.
Findings from a recent study by a team of Weill Cornell Medicine and NewYork-Presbyterian researchers explain why a bladder cancer patient responded exceptionally well to a targeted drug when others did not.
Dr. Katharine Hsu, M.D. ’94, Ph.D. ’93, professor of medicine and attending physician at Memorial Sloan Kettering Cancer Center, has been awarded the Weill Cornell Graduate School Alumni Award of Distinction.
The event, sponsored by the institution’s BioVenture eLab, is the culmination of a nine-week mentoring program that is designed to improve the ability of Weill Cornell Medicine clinicians and researchers to commercialize their concepts.